Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Schizophrenia: A meta-analysis of NAC augmentation in schizophrenia found significant improvements in total PANSS scores and negative symptoms (Yolland et al., Aust N Z J Psychiatry, 2020) [75]
The key is separating FDA-approved peptide medications (like the GLP-1s semaglutide and tirzepatide) from unapproved research peptides such as BPC-157 and injectable GHK-Cu, which have far less human evidence and an unsettled regulatory status
Gluten, Wheat & Dairy Free
Ready to see GHK-Cu
a 12-woman interstitial cystitis pilot (Lee, Walker & Ayadi, 2024)
US$ 25.68
US$ 27.53
US$ 26.74
US$ 23.88
US$ 23.56
